Terlivaz Injection, Powder, Lyophilized, For Solution
Product Images NDC 43825-200

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Terlivaz (NDC 43825-200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mallinckrodt Hospital Products Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Terlivaz 01)

A flowchart outlining a dosing adjustment protocol for Terlivaz (terlipressin) injection. It starts with an initial dose of 0.85 mg every 6 hours on Days 1-3, followed by assessment of serum creatinine on Day 4. Based on creatinine changes, it guides continuation, dose increase, or discontinuation, ending with treatment duration instructions.*

FDA Label Image

Chemical Structure (Terlivaz 02)

Chemical structure diagram illustrating the amino acid sequence of Terlipressin, shown as a chain of labeled amino acid residues arranged in a specific sequence representing the peptide structure.*

FDA Label Image

Principal Display Panel (0.85 mg Vial Carton)

Packaging label for Terlivaz terlipressin injection powder, lyophilized, for solution. The label shows a 0.85 mg single-dose vial for intravenous use, to be reconstituted with 5 mL of 0.9% Sodium Chloride Injection, USP. Distributed by Mallinckrodt Hospital Products Inc. and manufactured by Patheon Italia S.p.A. Storage instructions and product information are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.